Assistant Professor Katharina Quinlan is principal investigator on two new grants that could repurpose existing therapeutics to treat the disorder.Continue reading "$8.5 million in NIH grants support Ryan Institute research to help treat cerebral palsy"
Her inspiration, the biggest challenges in her work, and what makes her feel hopeful. Assistant Professor Jessica Alber investigates the potential to use retinal imaging as a screening tool for early-stage Alzheimer’s disease. Performed during a routine eye exam, the screening technique could help provide a low-cost, minimally invasive way to detect Alzheimer’s disease before […]Continue reading "Q&A: Jessica Alber, Ph.D."
Assistant Professor Jaime Ross and her lab report surprising findings on the impact of short-term microplastics exposure through drinking water.Continue reading "A new study investigates the impact of microplastics in the brain"
Ryan Institute Co-Executive Director William Van Nostrand answers questions about the potential risk of brain bleeds associated with newly-approved lecanemab and similar treatments. This summer, the FDA granted full approval to lecanemab, an antibody treatment for Alzheimer’s disease. The antibody—a protein that works by clearing amyloid-beta protein “plaques” in the brain, a signature of Alzheimer’s disease—has […]Continue reading "Q&A: The risks of brain bleeds in antibody treatments for Alzheimer’s disease"
William Van Nostrand, co-executive director of the George & Anne Ryan Institute for Neuroscience at the Univeristy of Rhode Island, is part of a team awarded a five-year, $8 million grant from the prestigious Leducq Foundation.Continue reading "Van Nostrand lab is part of $8 million grant for U.S. and European consortium on brain clearance in CAA"
Postdoc Graduate Students Undergraduate Students Liviana Donatelli (INP, Psy) Alex Burns (INP) Bhavya Chatragadda (INP, CMB-microbiology) Emilie Gastone (CMB) Past members – Undergrads Tinu Oladele Kofo Adebiyi Elizabeth MurphyContinue reading "People"
The Ryan Institute was pleased to welcome ten new faculty affiliates in Spring 2023 from the College of Pharmacy, College of Health Sciences, and College of Electrical, Computer, and Biomedical Engineering. Specializing in research areas that complement the institute’s focus on pathogenic mechanisms of neurodegenerative disease, our URI network of affiliated faculty are valuable partners […]Continue reading "New affiliated faculty members join the Ryan Institute"
April 27, 2023 URI neuroscience graduate students Emily Potts and Michelle Gregoire received awards at the Neuron 2023 research conference at Quinnipiac University’s Frank H. Netter MD School of Medicine on Sunday, April 23. The event was co-sponsored by the University of Connecticut. Students from the labs of Ryan Institute assistant professors Claudia Fallini and […]Continue reading "Graduate Students Receive Top Awards at Neuron 2023"
A new grant supports research by the Van Nostrand lab to investigate the effects of the ApoE 4 genotype in cerebral amyloid angiopathy, a disorder that commonly occurs with Alzheimer’s disease.Continue reading "New grant from Cure Alzheimer’s Fund supports research into the link between ApoE4 and CAA"
Assistant Professor Jess Alber answers questions about new research that supports her own work toward screening for Alzheimer’s disease during routine eye exams.Continue reading "Ryan Institute expert discusses new Alzheimer’s disease research showing that changes in the brain also can be seen in the eyes"